Fundraising Fox

Biotechnology Value Fund

San Francisco Β· Late Stage

Also known as BVF PARTNERS L.P.

✨ Fox Verdict
Sign up to see your fit
Stage
Late Stage
HQ
San Francisco, US
AUM
$6.1B
Tracked investments
1

What they invest in

from 1 of 1 portfolio companies

Biotech Γ—1

HQs:United StatesΓ—1

Investments Β· 1 tracked

founders shown can be your intro path
Contralinecontraline.com

BiotechCharlottesville, US

Kevin S Eisenfrats(Executive Officer, Director, Promoter)Iris Van Alderwerelt van Rosenburgh(Director)Martin J Emerson(Director)Gurdane Bhutani(Director)Tom Thorpe(Director)Michael King(Director)

Public market activity Β· per SEC filings

what is this? β“˜

500 insider ownership filings (Forms 3/4/5)

at XOMA Royalty Corp (XOMA), Kymera Therapeutics, Inc. (KYMR), Olema Pharmaceuticals, Inc. (OLMA), MoonLake Immunotherapeutics (MLTX), IMMUNIC, INC. (IMUX), Repare Therapeutics Inc. (RPTX), ESSA Pharma Inc. (EPIX), GLYCOMIMETICS INC (CBIO)

From the firm's own SEC EDGAR filings β€” stakes and insider roles in public companies, typically portfolio companies after an IPO. Not a portfolio list published by the firm.

Frequently asked questions

What stage does Biotechnology Value Fund invest at?
Biotechnology Value Fund invests at the Late Stage stage.
What sectors does Biotechnology Value Fund focus on?
Biotechnology Value Fund focuses on Biotech.
Where is Biotechnology Value Fund located?
Biotechnology Value Fund is headquartered in San Francisco, US.

Similar investors

Featured in lists